Publications

Search for Publications

List of Publications

Sort by: Date | Author | Title

Hybel, K. A., Erik lykke, M., Lambek, R. & Thomsen, P. H. (2017). Executive Function as a Predictor of Response to Cognitive-Behavioral Therapy for Childhood Obsessive-Compulsive Disorder. Abstract from The 47th Annual Congress of the European Association for Behavioral and Cognitive Therapies (EABCT'17), Ljubljana, Slovakia.
Hybel, K. A., Erik lykke, M., Lambek, R. & Thomsen, P. H. (2015). A Latent Variable Approach to Executive Function in Pediatric Obsessive-Compulsive Disorder. Poster session presented at ESCAP-European Society for Child and Adolescent Psychiatry, Madrid, Spain.
Rathcke, S. L., Sinding, M. M., Christensen, T. T., Uldbjerg, N., Christiansen, O. B., Kornblad, J., Søndergaard, K. H., Krogh, S. & Sørensen, A. N. W. (2024). Prediction of large-for-gestational-age at birth using fetal biometry in type 1 and type 2 diabetes: A retrospective cohort study. International Journal of Gynecology and Obstetrics, 167(2), 695-704. https://doi.org/10.1002/ijgo.15711
Badolato, R., Alsina, L., Azar, A., Bertrand, Y., Bolyard, A. A., Dale, D., Deyà-Martínez, À., Dickerson, K. E., Ezra, N., Hasle, H., Kang, H. J., Kiani-Alikhan, S., Kuijpers, T. W., Kulagin, A., Langguth, D., Levin, C., Neth, O., Olbrich, P., Peake, J. ... Donadieu, J. (2024). A phase 3 randomized trial of mavorixafor, a CXCR4 antagonist, for WHIM syndrome. Blood, 144(1), 35-45. https://doi.org/10.1182/blood.2023022658
McMahon, L., Maher, G. J., Joyce, C., Niemann, I., Fisher, R. & Sunde, L. (2024). When to Consult a Geneticist Specialising in Gestational Trophoblastic Disease. Gynecologic and Obstetric Investigation, 89(3), 198-213. https://doi.org/10.1159/000531218
Othman, J., Potter, N., Ivey, A., Tazi, Y., Papaemmanuil, E., Jovanovic, J., Freeman, S. D., Gilkes, A., Gale, R., Rapoz-D'Silva, T., Runglall, M., Kleeman, M., Dhami, P., Thomas, I., Johnson, S., Canham, J., Cavenagh, J., Kottaridis, P., Arnold, C. ... Dillon, R. (2024). Molecular, clinical, and therapeutic determinants of outcome in NPM1 mutated AML. Blood, 144(7), 714-728. https://doi.org/10.1182/blood.2024024310